Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterocyclic NMDA antagonists

Heterocyclic NMDA antagonists

US Patent 11834409 · Granted Dec 5, 2023

Estimated economic value: $65,497,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Macrocyclic compounds as proteasome inhibitors2025
Heterocyclic compound2025
Heterocyclic compounds having a calcium-sensing receptor antagonistic activity2025
Pyrrolo[1,2-c]imidazole derivatives as orexin type 2 receptor agonists2024
Heterocyclic compound and use thereof2024
Heterocyclic compound and use thereof2024
Heterocyclic compound and use thereof2024
Macrocyclic compounds as proteasome inhibitors2023
Heterocyclic NMDA antagonists2023
Heterocyclic NMDA antagonists2023
Heterocyclic NMDA antagonists2023
Crystalline forms of 2-[(2S)-1-azabicyclo[2.2.2]oct-2-yl]-6-(3-methyl-1H-pyrazol2023